| Year |
Citation |
Score |
| 2020 |
Kumar A, Teslova T, Taub E, Miller JD, Lukin DJ. Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications. Digestive Diseases and Sciences. PMID 32617771 DOI: 10.1007/S10620-020-06439-4 |
0.313 |
|
| 2020 |
Lukin DJ, Kumar A, Hajifathalian K, Sharaiha RZ, Scherl EJ, Longman RS. Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients with Inflammatory Bowel Disease. Gastroenterology. PMID 32479824 DOI: 10.1053/J.Gastro.2020.05.066 |
0.314 |
|
| 2020 |
Kumar A, Lukin D, Battat R, Schwartzman M, Mandl LA, Scherl E, Longman RS. Defining the phenotype, pathogenesis and treatment of Crohn's disease associated spondyloarthritis. Journal of Gastroenterology. PMID 32367294 DOI: 10.1007/S00535-020-01692-W |
0.316 |
|
| 2020 |
Axelrad J, Colombel JF, Scherl E, Lukin D, Chang S, Chen L, Kwah J, Swaminath A, Sultan K, Lawlor G, Villagra C, Galanko J, Sharpless V, Itzkowitz S. P729 The SAPPHIRE registry: Safety of immunosuppression in a prospective cohort of inflammatory bowel disease patients with a HIstoRy of CancEr Journal of Crohns & Colitis. 14. DOI: 10.1093/Ecco-Jcc/Jjz203.857 |
0.379 |
|
| 2019 |
Agrawal M, Cohen-Mekelburg S, Kayal M, Axelrad J, Galati J, Tricomi B, Kamal K, Faye AS, Abrudescu P, Scherl E, Lawlor G, Sultan K, Lukin D, Colombel JF, Ungaro RC. Disability in inflammatory bowel disease patients is associated with race, ethnicity and socio-economic factors. Alimentary Pharmacology & Therapeutics. PMID 30663075 DOI: 10.1111/Apt.15107 |
0.313 |
|
| 2018 |
Lukin DJ, Lawlor G, Hudesman DP, Durbin L, Axelrad JE, Passi M, Cavaliere K, Coburn E, Loftus M, Jen H, Feathers A, Rosen MH, Malter LB, Swaminath A. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile. Inflammatory Bowel Diseases. PMID 30312400 DOI: 10.1093/Ibd/Izy308 |
0.306 |
|
| 2018 |
Agrawal M, Cohen-Mekelburg S, Kayal M, Axelrad J, Galati J, Kamal K, Tricomi B, Faye A, Scherl E, Lawlor G, Lukin D, Colombel J-, Ungaro R. P826 Lower socioeconomic status is associated with disability in inflammatory bowel disease patients Journal of Crohn's and Colitis. 12: S533-S534. DOI: 10.1093/Ecco-Jcc/Jjx180.953 |
0.397 |
|
| 2015 |
Brave M, Lukin DJ, Mani S. Microbial control of intestinal innate immunity. Oncotarget. 6: 19962-3. PMID 26172839 DOI: 10.18632/Oncotarget.4780 |
0.304 |
|
| 2015 |
Lukin DJ, Carvajal LA, Liu WJ, Resnick-Silverman L, Manfredi JJ. p53 Promotes cell survival due to the reversibility of its cell-cycle checkpoints. Molecular Cancer Research : McR. 13: 16-28. PMID 25158956 DOI: 10.1158/1541-7786.Mcr-14-0177 |
0.541 |
|
| 2014 |
Westphalen CB, Asfaha S, Hayakawa Y, Takemoto Y, Lukin DJ, Nuber AH, Brandtner A, Setlik W, Remotti H, Muley A, Chen X, May R, Houchen CW, Fox JG, Gershon MD, et al. Long-lived intestinal tuft cells serve as colon cancer-initiating cells. The Journal of Clinical Investigation. 124: 1283-95. PMID 24487592 DOI: 10.1172/Jci73434 |
0.335 |
|
| 2014 |
Asfaha S, Westphalen CB, Hayakawa Y, Takemoto Y, Lukin DJ, Setlik W, Remotti H, Muley A, Chen X, May R, Houchen CW, Fox JG, Gershon MD, Quante M, Wang T. Abstract 4092: Long-lived Dclk1+ cells serve as colon cancer initiating cells Cancer Research. 74: 4092-4092. DOI: 10.1158/1538-7445.Am2014-4092 |
0.327 |
|
| 2012 |
Hamard PJ, Lukin DJ, Manfredi JJ. p53 basic C terminus regulates p53 functions through DNA binding modulation of subset of target genes. The Journal of Biological Chemistry. 287: 22397-407. PMID 22514277 DOI: 10.1074/Jbc.M111.331298 |
0.59 |
|
| Show low-probability matches. |